Iovance Biotherapeutics Market Risk Adjusted Performance
| IOVA Stock | | | USD 5.23 0.03 0.58% |
The Market Risk Adjusted Performance lookup presents technical context for Iovance Biotherapeutics and related instruments. Coverage depends on data availability and normalization;
Equity Screeners provides additional screening context. Iovance Biotherapeutics has market cap of 2.14 B, operating margin of -84.66%, ROE of -55.5%.
Risk vs Return Analysis can help frame allocation decisions. The allocation includes a position in Iovance Biotherapeutics in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
Get started with Iovance Stock investing by reading our
How to Invest in Iovance Stock guide.
Iovance Biotherapeutics has current Market Risk Adjusted Performance of 3.34.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 3.34 | |
| ER[a] | = | Expected return on investing in Iovance Biotherapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Iovance Biotherapeutics Market Risk Adjusted Performance Peers Comparison
Iovance Market Risk Adjusted Performance Relative To Other Indicators
Iovance Biotherapeutics is currently recognized as the top-ranked stock in market risk adjusted performance category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors reporting about
9.76 of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Iovance Biotherapeutics is roughly
9.76 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.